US measles cases outpace the whole of 2025 by 52% with months left to count

Widespread vaccination eliminated measles in the US in 2000. What ended then was sustained local transmission, while the virus kept circulating elsewhere ^[5]. A yearly case total measures volume. On the CDC count, 2026 is 1,182 cases, or about 52 percent, ahead of 2025, and the year's final months are still to come ^[1].

The outbreak figures come closer to the elimination question. The 95 percent of cases linked to outbreaks includes outbreaks that began in 2025 ^[3], so some chains of spread have crossed a calendar year. Continued circulation of that kind is what the endemic scenario describes: measles that keeps going instead of arriving in outbreaks that eventually stop ^[8]. The largest share of cases, 44 percent, is ages 5 to 19, roughly 1,527 people ^[4][2]. Discover links the rise to kindergarten MMR coverage below the 95 percent target, with deeper gaps in some communities ^[6]. It also cites more measles abroad reaching the US through travelers ^[7]. The link is drawn at the national level; the article does not tie individual outbreaks to local coverage figures.

The JAMA model Discover cites shows how steeply the outcome depends on coverage. Built on vaccination data from 2004 through 2023, its baseline projected 851,300 infections over 25 years ^[9]. A 10 percent relative decline in MMR vaccination raised that to 11.1 million. A 5 percent relative increase cut it to roughly 5,800 and kept measles from becoming endemic again ^[10]. Those two scenarios sit about 1,900-fold apart ^[4]. Both changes are relative to existing coverage, so a 10 percent decline means a tenth of current uptake, not ten percentage points ^[10]. Discover describes the results as conditional projections and cautions against reading them as a prediction from the September 2026 totals ^[11].

Congenital measles, infection passed from a pregnant person to the baby before birth, is the focus of the AAP guidance ^[12][13]. Its 25 to 30 percent transmission estimate for mothers infected shortly before delivery comes with the academy's own caveat that research remains limited ^[13]. The range is a working figure from a small evidence base ^[13]. Clinical signs are unreliable. Some infected newborns have fever, rash or jaundice, others show nothing at first, and multi-organ failure can develop quickly while neurological effects may appear later ^[14].

Exposure can happen without contact. Virus released by an infected patient can still infect someone who arrives in the same room two hours after that patient has left ^[16]. A pregnant woman can therefore be exposed in a waiting room without meeting anyone ill. MMR is a live-virus vaccine and cannot be given in pregnancy ^[15]. The AAP advises unvaccinated pregnant people who are exposed to contact their healthcare team promptly about immune globulin, which can protect after exposure ^[15]. Two MMR doses are about 97 percent effective, according to the CDC, and keeping others vaccinated shields those who cannot be, including pregnant women and newborns ^[17].